
Each delivered dose contains:
Fluticasone furoate 92 micrograms
Umeclidinium 55 micrograms
Vilanterol 22 micrograms
Other ingredients: Lactose monohydrate (contains milk proteins) and magnesium stearate.
Trelegy Ellipta Inhaler
Dosage: 92/55/22 micrograms per delivered dose
Pack size: 1 inhaler
Manufacturer: GlaxoSmithKline UK Limited (GSK)
Prescription required
Trelegy Ellipta is a prescription-only dry-powder inhaler containing three active ingredients: fluticasone furoate, umeclidinium and vilanterol.
It is licensed for maintenance treatment of adults with moderate to severe chronic obstructive pulmonary disease (COPD) who remain inadequately controlled on certain existing combination inhaler treatments.
The three active ingredients work together to reduce airway inflammation and help keep the airways open.
Trelegy Ellipta is a regular maintenance treatment and must not be used to relieve sudden breathing difficulties.
Each delivered dose contains:
Fluticasone furoate 92 micrograms
Umeclidinium 55 micrograms
Vilanterol 22 micrograms
Other ingredients: Lactose monohydrate (contains milk proteins) and magnesium stearate.